Survey finds early breast AI users report less recall and biopsy reduction than non-users anticipate

In a survey of 215 Society of Breast Imaging radiologists, 47% had already implemented AI for mammography detection. However, AI users reported significantly fewer reductions in recall rates (34.7% vs 59.3% anticipated by non-users, p=0.003), biopsy rates (9.1% vs 36.4%, p<0.001…

• 47% of 215 responding breast radiologists surveyed had integrated FDA-cleared breast cancer detection AI into practice; cost was the top barrier for non-adopters (53.3%).
• The most commonly perceived appropriate use for the AI tools was as a second reader, though only a minority of AI users reported meaningful clinical benefit across outcomes measured.
• Perceptions of patient outcomes did not differ significantly between AI users and non-users (p=0.87).

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.